Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Pharma faces a critical ‘turning point’ in 2026, years in the making
While Trump’s manufacturing and pricing deals with pharma shape the industry’s future, COVID’s impact still ripples throughout the health landscape.
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page